|
| 37730134 | Molecular pathways underlying lung-brain axis signaling in asthma: Relevance for psychopathology and neuroinflammation. | J Allergy Clin Immunol | 2024 |
| 37944567 | Gene-based association study of rare variants in children of diverse ancestries implicates TNFRSF21 in the development of allergic asthma. | J Allergy Clin Immunol | 2024 |
| 36283607 | Asthma Management in Adults. | J Allergy Clin Immunol Pract | 2023 |
| 37753239 | Major Publications in the Critical Care Pharmacotherapy Literature: 2022. | Crit Care Explor | 2023 |
| 37752621 | Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization. | Clin Exp Allergy | 2023 |
| 37659435 | Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma. | Respir Med | 2023 |
| 37638498 | Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization. | J Med Virol | 2023 |
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 37255285 | Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. | Clin Infect Dis | 2023 |
| 37147690 | Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. | Crit Care | 2023 |
| 37377978 | Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline. | Brain Commun | 2023 |
| 37277072 | Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): AÂ randomized controlled trial. | J Allergy Clin Immunol | 2023 |
| 37207831 | The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic Therapy. | J Allergy Clin Immunol Pract | 2023 |
| 37039791 | Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials. | JAMA | 2023 |
| 37073882 | Dupilumab improves long-term outcomes in patients with uncontrolled, moderate-to-severe GINA-based type 2 asthma, irrespective of allergic status. | Allergy | 2023 |
| 37301704 | Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022. | Vaccine | 2023 |
| 37096015 | Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics. | J Asthma Allergy | 2023 |
| 36963416 | Digital health in difficult-to-treat severe asthma. | Lancet Respir Med | 2023 |
| 36883903 | Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants. | J Infect Dis | 2023 |
| 36915284 | Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization. | J Asthma Allergy | 2023 |
| 36608946 | Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis. | Lancet Planet Health | 2023 |
| 36535524 | Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. | J Allergy Clin Immunol Pract | 2023 |
| 36503872 | Consequences of severe asthma exacerbations. | Curr Opin Allergy Clin Immunol | 2023 |
| 36638096 | Multi-omic association study identifies DNA methylation-mediated genotype and smoking exposure effects on lung function in children living in urban settings. | PLoS Genet | 2023 |
| 36524274 | Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support. | J Intensive Care Med | 2023 |
| 34536414 | Neuroimaging and biomarker evidence of neurodegeneration in asthma. | J Allergy Clin Immunol | 2022 |
| 35846157 | Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline. | Alzheimers Dement (N Y) | 2022 |
| 35618213 | Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP. | J Allergy Clin Immunol Pract | 2022 |
| 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clin Infect Dis | 2022 |
| 35818721 | Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness. | Influenza Other Respir Viruses | 2022 |
| 35783549 | Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia. | Crit Care Explor | 2022 |
| 35752431 | Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management. | J Allergy Clin Immunol Pract | 2022 |
| 35385875 | mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. | J Infect Dis | 2022 |
| 35413473 | Insights from the AUSTRI study on reliever use before and after asthma exacerbations. | J Allergy Clin Immunol Pract | 2022 |
| 36695662 | Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. | Open Forum Infect Dis | 2022 |
| 36208987 | Asthma exacerbations: the Achilles heel of asthma care. | Trends Mol Med | 2022 |
| 36177306 | Clinically relevant effects of Mindfulness-Based Stress Reduction in individuals with asthma. | Brain Behav Immun Health | 2022 |
| 35934678 | What has been learned by cytokine targeting of asthma? | J Allergy Clin Immunol | 2022 |
| 35964610 | Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial. | Lancet | 2022 |
| 36328374 | Improving systemic corticosteroid stewardship in asthma. | Eur Respir J | 2022 |
| 36028446 | Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype. | J Allergy Clin Immunol Pract | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 36216462 | Dupilumab and Eosinophils: A Red Flag? | J Allergy Clin Immunol Pract | 2022 |
| 36374708 | Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. | Vaccine | 2022 |
| 33709871 | Uncontrolled asthma across GINA treatment steps 2â¿¿-â¿¿5 in a large US patient cohort. | J Asthma | 2022 |
| 34954123 | Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies. | J Allergy Clin Immunol Pract | 2022 |
| 35149044 | Seasonal airway microbiome and transcriptome interactions promote childhood asthma exacerbations. | J Allergy Clin Immunol | 2022 |
| 35149042 | Weaving innate lymphoid cells (ILCs) into the fabric of asthma exacerbations. | J Allergy Clin Immunol | 2022 |
| 35272786 | Perspectives in Respiratory Infections and the Lung. | J Allergy Clin Immunol Pract | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |